Bone Cancer

+ -Text Size

Other Resources and References TOPICS

References: Bone cancer detailed guide

American Cancer Society. Cancer Facts and Figures, 2013. Atlanta, Ga: American Cancer Society; 2013.

American Joint Committee on Cancer. Bone. AJCC Cancer Staging Manual. 7th ed. New York:.Springer-Verlag; 2010: 281-287.

Bjornsson J, McLeod RA, Unni KK, et al. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998;83:1945-2008.

Bovee JV, Cleton-Jansen A, Taminiau AH, Hogendoom PCW. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncology. 2005;6:599-607.

Casali PG, Stacchiotti S, Grosso F, et al. Adding cisplatin (CDDP) to imatinib (IM) reestablishes tumor response following secondary resistance to IM in advanced chordoma. 2007 ASCO Annual Meeting Proceedings Part 1. J Clin Oncol. 2007 Jun 20;25 (18S): Abstract #10038.

Casali PG, Messina A, Stacchiotti S, et al. Imatinib mesylate in chordoma. Cancer. 2004 Nov 1;101(9):2086-97.

Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007 Jun;459:40-7.

Gebhardt MC, Springfield D, Neff JR. Sarcomas of bone. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa.: Elsevier; 2008: 2471-2572.

Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320-329.

Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009 May;91(5):1063-1072.

Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Miner Res. 2006 Dec;21 Suppl 2:P58-63.

Lewis DR, Ries LAG. Cancers of the bone and joint. In, Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Malawer MM, Helman LJ, O'Sullivan B. Sarcomas of bone. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2011: 1578-1609.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Bone Cancer. Version 2.2012. Accessed at on October 9, 2012.

Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). Accessed at on October 11, 2012.

Springfield D, Rosen G. Bone tumors. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine, 7th ed. Hamilton, Ontario: BC Decker; 2006: 1675-1693.

Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009 Nov;20(11):1886-94.

Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol. 2009 Jul;21(4):338-344.

Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010 Mar;11(3):275-80.

Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012 Feb;13(2):e69-76.

Last Medical Review: 11/29/2012
Last Revised: 06/13/2013